COMMUNIQUÉS West-GlobeNewswire

IntelGenx Announces Exercise of Over-Allotment Option
26/10/2018
SAINT LAURENT, Quebec, Oct. 26, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV:IGX) (OTCQX:IGXT) (the “ Company ” or “ IntelGenx ”) announces that in connection with its previously announced public offering [...]
Aduro Presents Preclinical Data for Anti-APRIL Antibody BION-1301 for the Treatment of IgA Nephropathy at ASN Kidney Week 2018
26/10/2018
BERKELEY, Calif., Oct. 26, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO) today announced preclinical data for its first-in-class anti-APRIL antibody BION-1301 supporting its use in the treatment of IgA [...]
Assurance Proves that an Engaging Work Culture Results in Happy Employees and a Great Place to Work
26/10/2018
SCHAUMBURG, Ill., Oct. 26, 2018 (GLOBE NEWSWIRE) -- Assurance employees have a lot of praise about working at the insurance brokerage; praise that has landed the organization a win on the 100 Best Medium Workplaces list [...]
RadNet, Inc. Announces Date of its Third Quarter 2018 Financial Results Conference Call
26/10/2018
LOS ANGELES, Oct. 26, 2018 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT) , a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient [...]
Altimmune to Present at Dawson James Securities 4th Annual Small Cap Growth Conference
26/10/2018
GAITHERSBURG, Md., Oct. 26, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage immunotherapeutics company, today announced that Bill Enright, President and Chief Executive Officer will provide a [...]
CRUZANI Snack Innovation: The MondoChurro!™
26/10/2018
Proprietary twist on a popular favorite by CRUZANI Oventa Foods ATLANTA, Oct. 26, 2018 (GLOBE NEWSWIRE) -- CRUZANI, Inc. (OTC: CZNI), www.CRUZANI.com , a global business development company focused on creating and [...]
New Clinical Trial Demonstrates Efficacy and Safety of Vayarin® Plus for Adults with ADHD
26/10/2018
COLUMBIA, Md., Oct. 26, 2018 (GLOBE NEWSWIRE) -- VAYA™ Pharma, Inc. (VAYA™), a division of Frutarom, Inc, and leader in developing specialty nutrition and medical food products, announced today that a new clinical trial [...]
Orion Corporation: Managers' transactions - Eija Ronkainen
26/10/2018
ORION CORPORATION MANAGERS' TRANSACTIONS 26 OCTOBER 2018 at 17.00 EEST Orion Corporation: Managers' transactions - Eija Ronkainen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU [...]
Anavex Life Sciences Presents New Three-Year, Longitudinal Clinical Efficacy Data for ANAVEX®2-73 in Alzheimer’s Disease at the 2018 Clinical Trials on Alzheimer’s Disease (CTAD) Meeting
26/10/2018
Late-Breaking Data Demonstrate Significant Association Between Higher ANAVEX®2-73 Concentration and Maintained Activities of Daily Living and Reduced Cognitive Decline in Alzheimer’s Disease Patients Data Confirm [...]
Biogen and Eisai Announce Presentation of Detailed Analyses from the Phase 1b Long-Term Extension Study of Aducanumab at Clinical Trials on Alzheimer’s Disease (CTAD)
26/10/2018
Three- and four-year data continued to show reduction in amyloid plaque and to suggest a slowing of the rate of clinical decline in patients CAMBRIDGE, Mass., Oct. 26, 2018 (GLOBE NEWSWIRE) -- Biogen (Nasdaq: BIIB) and [...]
Neuralstem Announces $2.1 Million Registered Direct Offering
26/10/2018
GERMANTOWN, Md., Oct. 26, 2018 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on developing novel treatments for nervous system diseases, today announced that it has entered into [...]
Adamas to Announce Third Quarter 2018 Financial Results and Host Conference Call on November 1, 2018
26/10/2018
EMERYVILLE, Calif., Oct. 26, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a fully-integrated pharmaceutical company pioneering time-dependent medicines for central nervous system disorders, [...]
Oral semaglutide demonstrates statistically significant reductions in HbA1c and body weight in people with long duration of type 2 diabetes treated with insulin
26/10/2018
Bagsværd, Denmark, 26 October 2018 - Novo Nordisk today announced the headline results from PIONEER 8, a phase 3a trial with oral semaglutide for the treatment of adults with type 2 diabetes. Oral semaglutide is an [...]
CrownBio lance MuBase® 2.0, une base de données en libre accès de modèles murins en immuno-oncologie
26/10/2018
Les mises à jour mettent en valeur l'expérience d'utilisateur, fournissent des données complètes de caractérisation et ajoutent de nouveaux modèles SAN DIEGO, 26 oct. 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, société [...]
Diversicare to Announce Third Quarter 2018 Financial Results on Thursday, November 1, 2018
26/10/2018
BRENTWOOD, Tenn., Oct. 26, 2018 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASDAQ:DVCR) today announced that it is scheduled to report financial results for its third quarter ended September 30, 2018, on [...]
FSD Pharma Doubles Down on Cannabinoid Therapeutics with Therapix Acquisition -- CFN Media
26/10/2018
SEATTLE, Oct. 26, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Clinical Genomics appoints Betsy Hanna as Chief Commercial Officer
26/10/2018
BRIDGEWATER, N.J., Oct. 26, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of cancer diagnostic solutions including liquid biopsy tests, today announced the appointment of Betsy Hanna as Chief Commercial [...]
RAMSAY GENERALE DE SANTE to complete the public offer to the shareholders of Capio
26/10/2018
PRESS RELEASE THIS PRESS RELEASE MAY NOT, DIRECTLY OR INDIRECTLY, BE DISTRIBUTED OR PUBLISHED IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, OR SOUTH AFRICA. THE OFFER IS NOT BEING MADE TO (AND ACCEPTANCES [...]
RAMSAY GENERALE DE SANTE finalise avec succès l'offre publique d'achat faite aux actionnaires de Capio
26/10/2018
COMMUNIQUE DE PRESSE LE PRESENT COMMUNIQUE DE PRESSE NE PEUT ETRE, DIRECTEMENT OU INDIRECTEMENT, DISTRIBUE OU PUBLIE EN AUSTRALIE, CANADA, HONG KONG, JAPON, NOUVELLE ZELANDE, OU AFRIQUE DU SUD. L'OFFRE N'EST PAS FAITE [...]

Pages